Category: Analysis - Page 4 - Psychedelic Alpha

Read more about the article Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Post published:January 10, 2025
Post category:Analysis News Pα+

Read more about the article From Fringe to Focus: APA’s American Journal of Psychiatry Publishes Special Issue on Psychedelics

From Fringe to Focus: APA’s American Journal of Psychiatry Publishes Special Issue on Psychedelics

Post published:January 7, 2025
Post category:Analysis News Pα+

Read more about the article Psychedelic Alpha’s Top 11 Stories from 2024

Psychedelic Alpha’s Top 11 Stories from 2024

Post published:December 26, 2024
Post category:2024 Year in Review Analysis News

Read more about the article SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

Post published:December 20, 2024
Post category:Analysis News Pα+

Read more about the article Psychedelic Drug Development Under Trump 2.0: Health Nominees Signal Uncertain Future

Psychedelic Drug Development Under Trump 2.0: Health Nominees Signal Uncertain Future

Post published:November 30, 2024
Post category:Analysis News Pα+

Read more about the article Q3’24 Survey: What are Psychedelics Investors Concerned About?

Q3’24 Survey: What are Psychedelics Investors Concerned About?

Post published:November 27, 2024
Post category:Analysis News Pα+

Read more about the article Interviews: Meet the Team Who Challenged the DEA on DOI and DOC

Interviews: Meet the Team Who Challenged the DEA on DOI and DOC

Post published:November 26, 2024
Post category:Analysis News

Read more about the article Q3’24 Survey: What are Psychedelics Investors Excited About?

Q3’24 Survey: What are Psychedelics Investors Excited About?

Post published:November 25, 2024
Post category:Analysis News Pα+

Read more about the article Psychedelic Investor Survey Q3 2024

Psychedelic Investor Survey Q3 2024

Post published:November 19, 2024
Post category:Analysis News

Read more about the article Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

Post published:November 18, 2024
Post category:Analysis News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.